The Zenitaka Corporation
Financial Summary for the Third Quarter of Fiscal Year Ending March 2026 [Japanese GAAP] (Consolidated)
Net sales for the third quarter of the fiscal year ending March 2026 amounted to 92,691 million yen (12.1% year-over-year increase), operating income was 3,474 million yen (113.6% YoY increase), and net income attributable to owners of parent for the quarter was 2,966 million yen (34.2% YoY increase).
Key Figures
- Net Sales: 92,691 million yen (12.1% year-over-year increase)
- Operating Income: 3,474 million yen (113.6% year-over-year increase)
- Net Income Attributable to Owners of Parent for the Quarter: 2,966 million yen (34.2% year-over-year increase)
AI要約
Overview of Business Results
Net sales for the consolidated cumulative third quarter of the fiscal year ending March 2026 were 92,691 million yen (12.1% year-over-year increase), composed of 90,683 million yen from the construction segment and 2,007 million yen from the real estate segment. Operating income was 3,474 million yen (113.6% YoY increase), ordinary income was 5,070 million yen (63.8% YoY increase), and net income attributable to owners of parent for the quarter was 2,966 million yen (34.2% YoY increase), achieving substantial profit growth. In the construction market, while private capital investment remains steady, material prices stay at elevated levels and labor costs show an upward trend, continuing a challenging management environment.
Overview of Financial Position and Future Outlook
At the end of the third quarter, total assets stood at 213,851 million yen (3.4% increase compared to the previous fiscal year-end), net assets were 110,504 million yen (14.1% increase), and the equity ratio improved to 51.7%. Liabilities decreased to 103,346 million yen (6.0% decrease), showing improvement in financial condition. Although the annual dividend forecast was revised downward to 110 yen (from 120 yen in the previous period), there is no change to the earnings guidance, and the company continues to aim for stable management.